ResMed Inc. — Income Charts
2 years of history · ending 2025-06-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$5.15B
Cost of Revenue
$2.09B
Gross Profit
$3.05B
R&D
$331M
SG&A
$991M
D&A
$198M
Operating Income
$1.69B
EBITDA
$1.88B
Interest Expense
$4M
Interest Income
—
Other Income/Expense
$-4M
Pretax Income
$1.68B
Tax Provision
$277M
Net Income
$1.40B
Gross Margin
59.4%
Operating Margin
32.7%
Net Margin
27.2%
Effective Tax Rate
16.5%
Deferred Tax Assets
$395M
Deferred Tax Liabilities
$220M
DTA Valuation Allowance
$30M
Tax Credit Carryforwards
$2M
NOL Carryforwards
$14M
ETR Federal Statutory
—
Operating Lease Cost
$39M
Revenue YoY Variation
9.8%
Income YoY Variation
27.7%